Associated Banc Corp Has $16.12 Million Stock Holdings in Danaher Co. (NYSE:DHR)

Associated Banc Corp cut its position in shares of Danaher Co. (NYSE:DHRFree Report) by 2.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 70,234 shares of the conglomerate’s stock after selling 1,850 shares during the period. Associated Banc Corp’s holdings in Danaher were worth $16,122,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Postrock Partners LLC acquired a new position in Danaher in the 4th quarter valued at about $725,000. LBP AM SA grew its stake in Danaher by 30.2% in the 4th quarter. LBP AM SA now owns 26,860 shares of the conglomerate’s stock valued at $6,166,000 after buying an additional 6,231 shares during the last quarter. Parnassus Investments LLC grew its position in shares of Danaher by 31.8% during the 4th quarter. Parnassus Investments LLC now owns 3,105,388 shares of the conglomerate’s stock worth $712,842,000 after purchasing an additional 749,136 shares in the last quarter. Sustainable Growth Advisers LP grew its position in shares of Danaher by 9.2% during the 4th quarter. Sustainable Growth Advisers LP now owns 3,232,010 shares of the conglomerate’s stock worth $741,908,000 after purchasing an additional 272,323 shares in the last quarter. Finally, Madison Investment Advisors LLC acquired a new position in shares of Danaher during the 4th quarter worth approximately $64,159,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Buying and Selling

In related news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 11.10% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the stock. Barclays decreased their target price on shares of Danaher from $275.00 to $240.00 and set an “equal weight” rating on the stock in a research report on Thursday, January 30th. Guggenheim assumed coverage on shares of Danaher in a research report on Thursday, December 19th. They set a “buy” rating and a $275.00 target price on the stock. Royal Bank of Canada restated an “outperform” rating and set a $277.00 target price (down previously from $299.00) on shares of Danaher in a research report on Thursday, January 30th. Bank of America upgraded shares of Danaher from a “neutral” rating to a “buy” rating and set a $290.00 target price on the stock in a research report on Friday, December 13th. Finally, Raymond James reaffirmed a “market perform” rating on shares of Danaher in a report on Monday, February 3rd. Six investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat.com, Danaher presently has a consensus rating of “Moderate Buy” and a consensus price target of $277.76.

Check Out Our Latest Stock Analysis on DHR

Danaher Price Performance

Shares of NYSE:DHR opened at $211.09 on Friday. The firm has a market cap of $150.87 billion, a PE ratio of 39.98, a price-to-earnings-growth ratio of 2.66 and a beta of 0.82. The firm’s fifty day moving average is $220.07 and its 200-day moving average is $240.82. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. Danaher Co. has a 52 week low of $196.80 and a 52 week high of $281.70.

Danaher (NYSE:DHRGet Free Report) last issued its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter last year, the firm earned $2.09 EPS. Sell-side analysts predict that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 0.61%. The ex-dividend date of this dividend is Friday, March 28th. This is an increase from Danaher’s previous quarterly dividend of $0.27. Danaher’s dividend payout ratio (DPR) is currently 24.24%.

Danaher Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

See Also

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.